126 - 150 of 34.985
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 395,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,07x
- Analysis
- Uber Technologies Call 85,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,02x
- Analysis
- Novo Nordisk Call 335,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 9,43x
- Analysis
- Chipotle Call 42,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 9,64x
- Analysis
- Cummins Inc Call 460,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 16,93x
- Analysis
- Accenture Call 260,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 9,59x
- Analysis
- Swiss Life Holding Call 920,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 21,36x
- Analysis
- Vertex Pharmaceuticalsorporated Call 380,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,64x
- Analysis
- Novo Nordisk Call 260,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,86x
- Analysis
- Lufthansa Call 9,50 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 11,88x
- Analysis
- Coinbase Call 260,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 2,93x
- Analysis
- Novo Nordisk Call 365,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,50x
- Analysis
- Novo Nordisk Call 540,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,99x
- Analysis
- Novo Nordisk Call 375,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,81x
- Analysis
- Novo Nordisk Call 520,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,52x
- Analysis
- PepsiCo Call 155,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 24,35x
- Analysis
- Alphabet Call 250,00 12 Sep 2025
- Goldman Sachs
- 12.09.25
- 18,27x
- Analysis
- Target Corp Call 180,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 9,98x
- Analysis
- Accenture Call 350,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 9,11x
- Analysis
- Novo Nordisk Call 510,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,11x
- Analysis
- Cisco Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 13,38x
- Analysis
- Accenture Call 250,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,73x
- Analysis
- GE (General Electric) Call 290,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 17,11x
- Analysis
- Amazon.com Call 340,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,18x
- Analysis
- Novo Nordisk Call 270,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,08x
- Analysis